Schedule 13D ownership disclosure

Aurinia Pharmaceuticals Inc

Security class unavailable · CUSIP: 05156V102

Event date: 2017-03-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-016590
Form type
SC 13D/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Mar 27, 2017
Reporting period
Mar 20, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub